Insiders · Profile

Scots-Knight Denise

Chief Executive Officer at Mereo BioPharma. Filing since 25 Jun 2024. CIK 0001297000

Company
Date
Role
Action
Shares
Amount
Of holding
13 Sep 2024
Chief Executive Officer
Sold at will
60,046
$253.45K
6.9%
12 Sep 2024
Chief Executive Officer
Sold at will
28,611
$127.97K
3.2%
26 Jun 2024
Chief Executive Officer
Sold at will
92,273
$313.10K
11.5%
25 Jun 2024
Chief Executive Officer
Sold at will
40,712
$150.39K
4.8%
4 decisions on file.